BEVERLY HILLS, CA / ACCESS Newswire / July 18, 2025 / World-renowned spinal neurosurgeon and motion preservation expert Dr.

VIVEX Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatment options, today announced that results from the company’s VAST study ...

Patients with degenerative disc disease genetically different than those without the condition Study finds patients with DDD are genetically predisposed to develop chronic pain after injury.

The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Dymicron to ...

DALLAS, March 9, 2015 /PRNewswire/ --. RnRMarketResearch.com adds "Degenerative Disc Disease - Pipeline Review, H1 2015" therapeutic market research report of 72 pages with latest updates, data ...

Stem cell transplants was found to be viable and effective for halting or reversing degenerative disc disease in the spine, based on research conducted at the Mayo Clinic and presented at the ...